| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphopyruvate hydratase activity | 5.96e-07 | 4 | 107 | 3 | GO:0004634 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 2.96e-06 | 6 | 107 | 3 | GO:0055131 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 2.79e-05 | 163 | 107 | 7 | GO:0031072 | |
| GeneOntologyMolecularFunction | denatured protein binding | 8.50e-05 | 3 | 107 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | misfolded protein binding | 1.15e-04 | 18 | 107 | 3 | GO:0051787 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 2.81e-04 | 5 | 107 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | Hsp70 protein binding | 3.64e-04 | 63 | 107 | 4 | GO:0030544 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 4.21e-04 | 6 | 107 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | calcium ion binding | S100G DSC3 PCDHGA9 ANXA3 MATN1 SPTA1 SYT2 NRXN1 SCIN PCDH1 PCDH7 PROS1 | 6.75e-04 | 749 | 107 | 12 | GO:0005509 |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 9.39e-04 | 36 | 107 | 3 | GO:0140416 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 9.99e-04 | 9 | 107 | 2 | GO:0001181 | |
| GeneOntologyBiologicalProcess | negative regulation of inclusion body assembly | 2.73e-05 | 12 | 105 | 3 | GO:0090084 | |
| GeneOntologyBiologicalProcess | NADH metabolic process | 6.12e-05 | 42 | 105 | 4 | GO:0006734 | |
| GeneOntologyBiologicalProcess | nicotinamide nucleotide metabolic process | 7.88e-05 | 202 | 105 | 7 | GO:0046496 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide metabolic process | 7.88e-05 | 202 | 105 | 7 | GO:0019362 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound metabolic process | 1.00e-04 | 210 | 105 | 7 | GO:0072524 | |
| GeneOntologyBiologicalProcess | regulation of inclusion body assembly | 1.59e-04 | 21 | 105 | 3 | GO:0090083 | |
| GeneOntologyBiologicalProcess | NADH regeneration | 1.59e-04 | 21 | 105 | 3 | GO:0006735 | |
| GeneOntologyBiologicalProcess | canonical glycolysis | 1.59e-04 | 21 | 105 | 3 | GO:0061621 | |
| GeneOntologyBiologicalProcess | glucose catabolic process to pyruvate | 1.59e-04 | 21 | 105 | 3 | GO:0061718 | |
| GeneOntologyCellularComponent | phosphopyruvate hydratase complex | 5.34e-07 | 4 | 108 | 3 | GO:0000015 | |
| GeneOntologyCellularComponent | actin cytoskeleton | FLNC CTTNBP2 SPTA1 RGS22 ARHGAP35 NEB COTL1 MTPN CTNNA1 SCIN VCAM1 | 1.95e-04 | 576 | 108 | 11 | GO:0015629 |
| Domain | Enolase_N | 1.78e-07 | 3 | 106 | 3 | PF03952 | |
| Domain | Enolase | 1.78e-07 | 3 | 106 | 3 | IPR000941 | |
| Domain | Enolase_C | 1.78e-07 | 3 | 106 | 3 | IPR020810 | |
| Domain | Enolase_N | 1.78e-07 | 3 | 106 | 3 | IPR020811 | |
| Domain | Enolase_CS | 1.78e-07 | 3 | 106 | 3 | IPR020809 | |
| Domain | Enolase_C | 1.78e-07 | 3 | 106 | 3 | PF00113 | |
| Domain | Enolase_N | 1.78e-07 | 3 | 106 | 3 | SM01193 | |
| Domain | Enolase_C | 1.78e-07 | 3 | 106 | 3 | SM01192 | |
| Domain | ENOLASE | 1.78e-07 | 3 | 106 | 3 | PS00164 | |
| Domain | - | 7.08e-07 | 4 | 106 | 3 | 3.30.390.10 | |
| Domain | - | 7.08e-07 | 4 | 106 | 3 | 3.20.20.120 | |
| Domain | Enolase_C-like | 7.08e-07 | 4 | 106 | 3 | IPR029065 | |
| Domain | Enolase_N-like | 7.08e-07 | 4 | 106 | 3 | IPR029017 | |
| Domain | Cl_channel-K | 3.19e-05 | 2 | 106 | 2 | IPR002250 | |
| Domain | - | 9.54e-05 | 3 | 106 | 2 | 3.40.710.10 | |
| Domain | Beta-lactam/transpept-like | 9.54e-05 | 3 | 106 | 2 | IPR012338 | |
| Domain | Cortactin-binding_p2_N | 1.90e-04 | 4 | 106 | 2 | IPR019131 | |
| Domain | CortBP2 | 1.90e-04 | 4 | 106 | 2 | PF09727 | |
| Domain | Protocadherin | 3.16e-04 | 5 | 106 | 2 | PF08374 | |
| Domain | Protocadherin | 3.16e-04 | 5 | 106 | 2 | IPR013585 | |
| Domain | Histone_H5 | 8.74e-04 | 8 | 106 | 2 | IPR005819 | |
| Domain | Cl-channel_core | 1.12e-03 | 9 | 106 | 2 | IPR014743 | |
| Domain | - | 1.12e-03 | 9 | 106 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 1.12e-03 | 9 | 106 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 1.12e-03 | 9 | 106 | 2 | IPR001807 | |
| Domain | LAM_G_DOMAIN | 1.30e-03 | 38 | 106 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 1.51e-03 | 40 | 106 | 3 | PF02210 | |
| Domain | LamG | 1.99e-03 | 44 | 106 | 3 | SM00282 | |
| Domain | H15 | 2.39e-03 | 13 | 106 | 2 | SM00526 | |
| Domain | Linker_histone | 2.39e-03 | 13 | 106 | 2 | PF00538 | |
| Domain | H15 | 2.39e-03 | 13 | 106 | 2 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 2.78e-03 | 14 | 106 | 2 | IPR005818 | |
| Domain | Sushi | 3.21e-03 | 52 | 106 | 3 | PF00084 | |
| Domain | Cadherin_CS | 3.45e-03 | 109 | 106 | 4 | IPR020894 | |
| Domain | CCP | 3.57e-03 | 54 | 106 | 3 | SM00032 | |
| Domain | CBS | 3.64e-03 | 16 | 106 | 2 | SM00116 | |
| Domain | HSP70 | 3.64e-03 | 16 | 106 | 2 | PF00012 | |
| Domain | CADHERIN_1 | 3.93e-03 | 113 | 106 | 4 | PS00232 | |
| Domain | Cadherin | 3.93e-03 | 113 | 106 | 4 | PF00028 | |
| Domain | SUSHI | 3.96e-03 | 56 | 106 | 3 | PS50923 | |
| Domain | VWA | 3.96e-03 | 56 | 106 | 3 | PF00092 | |
| Domain | CADHERIN_2 | 4.06e-03 | 114 | 106 | 4 | PS50268 | |
| Domain | - | 4.06e-03 | 114 | 106 | 4 | 2.60.40.60 | |
| Domain | HSP70_2 | 4.10e-03 | 17 | 106 | 2 | PS00329 | |
| Domain | HSP70_1 | 4.10e-03 | 17 | 106 | 2 | PS00297 | |
| Domain | HSP70_3 | 4.10e-03 | 17 | 106 | 2 | PS01036 | |
| Domain | Sushi_SCR_CCP_dom | 4.16e-03 | 57 | 106 | 3 | IPR000436 | |
| Domain | CA | 4.18e-03 | 115 | 106 | 4 | SM00112 | |
| Domain | Cadherin-like | 4.31e-03 | 116 | 106 | 4 | IPR015919 | |
| Domain | Laminin_G | 4.37e-03 | 58 | 106 | 3 | IPR001791 | |
| Domain | Cadherin | 4.58e-03 | 118 | 106 | 4 | IPR002126 | |
| Domain | Hsp_70_fam | 4.60e-03 | 18 | 106 | 2 | IPR013126 | |
| Domain | CBS_dom | 5.67e-03 | 20 | 106 | 2 | IPR000644 | |
| Domain | CBS | 5.67e-03 | 20 | 106 | 2 | PF00571 | |
| Domain | CBS | 5.67e-03 | 20 | 106 | 2 | PS51371 | |
| Pubmed | FLNC CTTNBP2 SPTA1 DNAJB6 ALDH1L1 ARHGAP35 MDH1 COTL1 LACTB UBA1 OGDHL CTNNA1 HSPA1A HSPA1B PCDH1 ENO2 SNRNP200 PRRC2B CNTN1 | 8.44e-08 | 1431 | 108 | 19 | 37142655 | |
| Pubmed | A Moonlighting Human Protein Is Involved in Mitochondrial Import of tRNA. | 1.16e-07 | 4 | 108 | 3 | 25918939 | |
| Pubmed | FLNC DSC3 AGPS NEB COTL1 MTPN GLS H1-1 CTNNA1 ASPRV1 DNAJA1 HSPA1A ENO1 SNRNP200 | 3.74e-07 | 844 | 108 | 14 | 25963833 | |
| Pubmed | FLNC TES GATAD2B FSIP2 UBA1 HTATSF1 DNAJA1 HSPA1A HSPA1B BAG6 | 5.03e-07 | 399 | 108 | 10 | 35987950 | |
| Pubmed | RING finger protein RNF207, a novel regulator of cardiac excitation. | 5.78e-07 | 6 | 108 | 3 | 25281747 | |
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 19433310 | ||
| Pubmed | DSC3 PBDC1 DNAJB6 LACTB MTPN TXNL1 GLS SLMAP RETREG1 HTATSF1 CTNNA1 CRYBG3 DNAJA1 HSPA1A HSPA1B PCDH7 SNRNP200 BAG6 | 7.40e-07 | 1487 | 108 | 18 | 33957083 | |
| Pubmed | The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities. | 7.44e-07 | 23 | 108 | 4 | 21231916 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | DNAJB6 COTL1 UBA1 SYNJ2 DNAJA1 HSPA1A HSPA1B ENO2 ENO3 SNRNP200 BAG6 CNOT3 | 1.13e-06 | 665 | 108 | 12 | 30457570 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CFH ANXA3 ALDH1L1 MDH1 COTL1 CFB UBA1 HSPA1A ENO1 HSPA1B ENO2 ENO3 VCAM1 CNTN1 PROS1 | 1.15e-06 | 1070 | 108 | 15 | 23533145 |
| Pubmed | PFGE mapping and RFLP analysis of the S/D region of the mouse H-2 complex. | 1.61e-06 | 8 | 108 | 3 | 1351875 | |
| Pubmed | FLNC PCDHGA9 SPTA1 DNAJB6 NEB TRNT1 NRXN1 SCG3 GLS RETREG1 H1-5 OGDHL H1-1 DNAJA1 KIAA2012 ENO1 PRRC2B | 2.23e-06 | 1442 | 108 | 17 | 35575683 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | FLNC TES PBDC1 PPID MTPN TXNL1 UBA1 TRNT1 GLS H1-5 HTATSF1 CTNNA1 DNAJA1 HSPA1A ENO2 SNRNP200 BAG6 | 2.52e-06 | 1455 | 108 | 17 | 22863883 |
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 7629134 | ||
| Pubmed | FLNC CTTNBP2 DNAJB6 LAMA4 NEB SLMAP RETREG1 ENO1 HSPA1B ENO3 | 3.60e-06 | 497 | 108 | 10 | 23414517 | |
| Pubmed | Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress. | 4.64e-06 | 78 | 108 | 5 | 16236267 | |
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 24318877 | ||
| Pubmed | FIH Regulates Cellular Metabolism through Hydroxylation of the Deubiquitinase OTUB1. | 4.80e-06 | 138 | 108 | 6 | 26752685 | |
| Pubmed | 5.14e-06 | 215 | 108 | 7 | 35973513 | ||
| Pubmed | Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. | 5.90e-06 | 143 | 108 | 6 | 30397336 | |
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 12150907 | ||
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 24399297 | ||
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 7993390 | ||
| Pubmed | Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. | 7.50e-06 | 86 | 108 | 5 | 10862698 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TES DSC3 ANXA3 DNAJB6 LACTB UBA1 GLS SLMAP H1-5 CTNNA1 DNAJA1 ENO1 HSPA1B SNRNP200 RSBN1L | 8.12e-06 | 1257 | 108 | 15 | 36526897 |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 8.73e-06 | 327 | 108 | 8 | 15592455 | |
| Pubmed | 9.54e-06 | 331 | 108 | 8 | 29199018 | ||
| Pubmed | Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. | 9.55e-06 | 2 | 108 | 2 | 12411538 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 2868009 | ||
| Pubmed | Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients. | 9.55e-06 | 2 | 108 | 2 | 24328534 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 3786141 | ||
| Pubmed | The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. | 9.55e-06 | 2 | 108 | 2 | 27335120 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 30779465 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 8812470 | ||
| Pubmed | Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides. | 9.55e-06 | 2 | 108 | 2 | 26923070 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 25919862 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 16482515 | ||
| Pubmed | Sequential interplay between BAG6 and HSP70 upon heat shock. | 9.55e-06 | 2 | 108 | 2 | 19357808 | |
| Pubmed | Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. | 9.55e-06 | 2 | 108 | 2 | 11864979 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 2090519 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15719414 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26976620 | ||
| Pubmed | Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. | 9.55e-06 | 2 | 108 | 2 | 21187371 | |
| Pubmed | Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer. | 9.55e-06 | 2 | 108 | 2 | 20430459 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20235222 | ||
| Pubmed | Genetic determinants of HSP70 gene expression following heat shock. | 9.55e-06 | 2 | 108 | 2 | 20876613 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20223214 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20093776 | ||
| Pubmed | Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells. | 9.55e-06 | 2 | 108 | 2 | 23704948 | |
| Pubmed | Structure and expression of the human gene encoding major heat shock protein HSP70. | 9.55e-06 | 2 | 108 | 2 | 2858050 | |
| Pubmed | Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss. | 9.55e-06 | 2 | 108 | 2 | 38069401 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17513788 | ||
| Pubmed | IL-6 activates HSP72 gene expression in human skeletal muscle. | 9.55e-06 | 2 | 108 | 2 | 12207910 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 28837204 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 29572464 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15988927 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26448330 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12714332 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 19299581 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11713291 | ||
| Pubmed | Heat shock protein 72 (Hsp72) improves long term recovery after focal cerebral ischemia in mice. | 9.55e-06 | 2 | 108 | 2 | 21108992 | |
| Pubmed | HUPO BPP pilot study: a proteomics analysis of the mouse brain of different developmental stages. | 9.55e-06 | 2 | 108 | 2 | 17922513 | |
| Pubmed | Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70). | 9.55e-06 | 2 | 108 | 2 | 31320473 | |
| Pubmed | A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels. | 9.55e-06 | 2 | 108 | 2 | 20805576 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 16971451 | ||
| Pubmed | Co-chaperones DNAJA1 and DNAJB6 are critical for regulation of polyglutamine aggregation. | 9.55e-06 | 2 | 108 | 2 | 32424160 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 29631603 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21757701 | ||
| Pubmed | Role of membrane Hsp70 in radiation sensitivity of tumor cells. | 9.55e-06 | 2 | 108 | 2 | 26197988 | |
| Pubmed | Hsp72 overexpression accelerates the recovery from caerulein-induced pancreatitis. | 9.55e-06 | 2 | 108 | 2 | 22792201 | |
| Pubmed | Salt wasting and deafness resulting from mutations in two chloride channels. | 9.55e-06 | 2 | 108 | 2 | 15044642 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9820195 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 19157555 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 37298493 | ||
| Pubmed | Two highly homologous members of the ClC chloride channel family in both rat and human kidney. | 9.55e-06 | 2 | 108 | 2 | 8041726 | |
| Pubmed | A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane. | 9.55e-06 | 2 | 108 | 2 | 18648499 | |
| Pubmed | Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney. | 9.55e-06 | 2 | 108 | 2 | 8544406 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 25618331 | ||
| Pubmed | Extracellular heat shock protein 72 is a marker of the stress protein response in acute lung injury. | 9.55e-06 | 2 | 108 | 2 | 16679378 | |
| Pubmed | Nucleotide sequences of cDNAs alpha and gamma enolase mRNAs from mouse brain. | 9.55e-06 | 2 | 108 | 2 | 2362815 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 19639652 | ||
| Pubmed | Complement factor H is expressed in adipose tissue in association with insulin resistance. | 9.55e-06 | 2 | 108 | 2 | 19833879 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22551201 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 16100242 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15498567 | ||
| Pubmed | Biological activity of truncated C-terminus human heat shock protein 72. | 9.55e-06 | 2 | 108 | 2 | 21094186 | |
| Pubmed | Geranylgeranylaceton induces heat shock protein 72 in skeletal muscle cells. | 9.55e-06 | 2 | 108 | 2 | 17482577 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24863058 | ||
| Pubmed | Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. | 9.55e-06 | 2 | 108 | 2 | 9916798 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9916791 | ||
| Pubmed | Structure and expression of an inducible HSP70-encoding gene from Mus musculus. | 9.55e-06 | 2 | 108 | 2 | 8076831 | |
| Pubmed | The 70 kDa heat shock protein protects against experimental traumatic brain injury. | 9.55e-06 | 2 | 108 | 2 | 23816752 | |
| Pubmed | Complete structure of the human gene encoding neuron-specific enolase. | 9.55e-06 | 2 | 108 | 2 | 2045099 | |
| Pubmed | Structure of a new crystal form of human Hsp70 ATPase domain. | 9.55e-06 | 2 | 108 | 2 | 10216320 | |
| Pubmed | Isolation of murine neuron-specific and non-neuronal enolase cDNA clones. | 9.55e-06 | 2 | 108 | 2 | 3801001 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 14672969 | ||
| Pubmed | Genetic Modulation of HSPA1A Accelerates Kindling Progression and Exerts Pro-convulsant Effects. | 9.55e-06 | 2 | 108 | 2 | 29964156 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 3019832 | ||
| Pubmed | Sequence analysis of HSPA1A and HSPA1B in a multi-ethnic study population. | 9.55e-06 | 2 | 108 | 2 | 17364813 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24430435 | ||
| Interaction | SGCG interactions | 1.51e-07 | 24 | 107 | 5 | int:SGCG | |
| Interaction | TAGLN2 interactions | 2.65e-06 | 220 | 107 | 9 | int:TAGLN2 | |
| Interaction | CLTA interactions | TES DNAJB6 CCNF TXNL1 SYNJ2 DNAJA1 HSPA1A ENO1 HSPA1B CNOT3 VCAM1 | 2.67e-06 | 351 | 107 | 11 | int:CLTA |
| Interaction | HSD17B10 interactions | FLNC RC3H1 MDH1 CCNF UBA1 SPIN1 CTNNA1 HSPA1A ENO1 ENO2 ENO3 PCDH7 | 3.34e-06 | 434 | 107 | 12 | int:HSD17B10 |
| Interaction | MCM2 interactions | FLNC DSC3 AGPS NEB COTL1 MTPN CCNF SPIN1 GLS H1-1 CTNNA1 ASPRV1 DNAJA1 HSPA1A ENO1 SNRNP200 CNOT3 VCAM1 CDK6 | 3.76e-06 | 1081 | 107 | 19 | int:MCM2 |
| Interaction | PSMD14 interactions | RGS22 ALDH1L1 CCNF TXNL1 UBA1 H1-5 H1-1 DNAJA1 HSPA1A ENO1 HSPA1B BAG6 RSBN1L | 4.44e-06 | 527 | 107 | 13 | int:PSMD14 |
| Interaction | USP11 interactions | SPTA1 ALDH1L1 CCNF UBA1 H1-1 CTNNA1 DNAJA1 HSPA1A ENO1 HSPA1B ENO3 SNRNP200 PRRC2B | 5.66e-06 | 539 | 107 | 13 | int:USP11 |
| Interaction | SUMO4 interactions | 6.48e-06 | 86 | 107 | 6 | int:SUMO4 | |
| Interaction | EZR interactions | TRAF3 SPTA1 ARHGAP35 CCNF STK10 UBA1 TRNT1 CTNNA1 HSPA1A ENO1 ENO2 PCDH7 VCAM1 | 7.46e-06 | 553 | 107 | 13 | int:EZR |
| Interaction | H3C15 interactions | 1.48e-05 | 207 | 107 | 8 | int:H3C15 | |
| Interaction | HDAC5 interactions | IKZF2 DNAJB6 MDH1 CFB UBA1 DNAJA1 HSPA1A ENO1 ENO2 ENO3 SNRNP200 | 1.89e-05 | 432 | 107 | 11 | int:HDAC5 |
| Interaction | STIP1 interactions | ANXA3 DNAJB6 NEB PPID CCNF UBA1 CTNNA1 DNAJA1 HSPA1A ENO1 HSPA1B ENO2 ENO3 PCDH7 SNRNP200 BAG6 VCAM1 | 2.16e-05 | 1006 | 107 | 17 | int:STIP1 |
| Interaction | MAPT interactions | FLNC ALDH1L1 MDH1 PPID COTL1 CCNF FSIP2 UBA1 SCG3 GLS HTATSF1 CTNNA1 DNAJA1 HSPA1A PCDH1 ENO2 BAG6 CNTN1 | 2.32e-05 | 1119 | 107 | 18 | int:MAPT |
| Interaction | UBE2A interactions | 2.78e-05 | 226 | 107 | 8 | int:UBE2A | |
| Interaction | AIFM1 interactions | FLNC TES RC3H1 LACTB CCNF STK10 GLS H1-1 CRYBG3 DNAJA1 HSPA1A HSPA1B BAG6 | 2.90e-05 | 629 | 107 | 13 | int:AIFM1 |
| Interaction | CTH interactions | 3.53e-05 | 70 | 107 | 5 | int:CTH | |
| Interaction | SF1 interactions | 3.53e-05 | 304 | 107 | 9 | int:SF1 | |
| Interaction | AARS1 interactions | 3.58e-05 | 171 | 107 | 7 | int:AARS1 | |
| Interaction | MSX1 interactions | 3.88e-05 | 36 | 107 | 4 | int:MSX1 | |
| Interaction | HINT1 interactions | 4.30e-05 | 176 | 107 | 7 | int:HINT1 | |
| Interaction | PDIA3 interactions | MTPN CCNF FSIP2 SYNJ2 ING4 DNAJA1 HSPA1A ENO1 HSPA1B PCDH7 FILIP1L | 4.58e-05 | 476 | 107 | 11 | int:PDIA3 |
| Interaction | H2BC18 interactions | 4.96e-05 | 180 | 107 | 7 | int:H2BC18 | |
| Interaction | EEF1A1 interactions | RC3H1 PBDC1 LAMA4 PPID CCNF TXNL1 UBA1 H1-5 CTNNA1 HSPA1A ENO2 ENO3 SNRNP200 VCAM1 | 5.08e-05 | 762 | 107 | 14 | int:EEF1A1 |
| Interaction | ARHGDIA interactions | 5.32e-05 | 182 | 107 | 7 | int:ARHGDIA | |
| Interaction | NPM1 interactions | FLNC RC3H1 NEB PPID CCNF SPIN1 H1-5 H1-1 DNAJA1 HSPA1A ENO1 HSPA1B PCDH7 SNRNP200 RSBN1L VCAM1 PRRC2B PROS1 | 5.85e-05 | 1201 | 107 | 18 | int:NPM1 |
| Interaction | CDC34 interactions | 6.36e-05 | 328 | 107 | 9 | int:CDC34 | |
| Interaction | PKM interactions | SNRNP27 RC3H1 DNAJB6 PPID CCNF NRXN1 HSPA1A ENO1 ENO2 ENO3 PCDH7 | 6.75e-05 | 497 | 107 | 11 | int:PKM |
| Interaction | KRT18 interactions | TES DNAJB6 TXNL1 UBA1 CTNNA1 CRYBG3 HSPA1A PCDH7 VCAM1 CNTN1 | 7.91e-05 | 419 | 107 | 10 | int:KRT18 |
| Interaction | RAVER1 interactions | 7.96e-05 | 194 | 107 | 7 | int:RAVER1 | |
| Interaction | PRDX6 interactions | 8.76e-05 | 266 | 107 | 8 | int:PRDX6 | |
| Interaction | DDTL interactions | 9.37e-05 | 17 | 107 | 3 | int:DDTL | |
| Interaction | TARDBP interactions | DNAJB6 MDH1 CCNF UBA1 SCIN HSPA1A ENO1 ENO2 SNRNP200 BAG6 VCAM1 | 1.01e-04 | 520 | 107 | 11 | int:TARDBP |
| Interaction | ARAP1 interactions | 1.12e-04 | 47 | 107 | 4 | int:ARAP1 | |
| Interaction | FABP5 interactions | 1.44e-04 | 149 | 107 | 6 | int:FABP5 | |
| Interaction | UBA6 interactions | 1.50e-04 | 150 | 107 | 6 | int:UBA6 | |
| Interaction | NT5C3B interactions | 1.55e-04 | 20 | 107 | 3 | int:NT5C3B | |
| Interaction | SRSF2 interactions | 1.59e-04 | 290 | 107 | 8 | int:SRSF2 | |
| Interaction | ACTA1 interactions | 1.62e-04 | 371 | 107 | 9 | int:ACTA1 | |
| Interaction | CNTNAP5 interactions | 1.66e-04 | 4 | 107 | 2 | int:CNTNAP5 | |
| Interaction | CHN2 interactions | 1.68e-04 | 97 | 107 | 5 | int:CHN2 | |
| Interaction | UBE2M interactions | DNAJB6 MDH1 COTL1 CCNF UBA1 SPIN1 HTATSF1 DNAJA1 HSPA1A ENO1 SNRNP200 VCAM1 | 1.76e-04 | 651 | 107 | 12 | int:UBE2M |
| Interaction | ARAF interactions | 1.79e-04 | 376 | 107 | 9 | int:ARAF | |
| Interaction | ACTB interactions | FLNC TES CTTNBP2 AGPS ARHGAP35 NEB COTL1 GATAD2B CCNF FSIP2 RRN3 H1-1 CTNNA1 SCIN HSPA1A VCAM1 | 1.86e-04 | 1083 | 107 | 16 | int:ACTB |
| Interaction | BAG4 interactions | 1.94e-04 | 224 | 107 | 7 | int:BAG4 | |
| Interaction | TTN interactions | 1.96e-04 | 299 | 107 | 8 | int:TTN | |
| Interaction | NAA15 interactions | 1.99e-04 | 158 | 107 | 6 | int:NAA15 | |
| Interaction | ANKRD17 interactions | 2.05e-04 | 226 | 107 | 7 | int:ANKRD17 | |
| Interaction | HIP1R interactions | 2.06e-04 | 159 | 107 | 6 | int:HIP1R | |
| Interaction | TBCA interactions | 2.13e-04 | 102 | 107 | 5 | int:TBCA | |
| Interaction | FLNB interactions | 2.19e-04 | 304 | 107 | 8 | int:FLNB | |
| Interaction | HSPE1 interactions | 2.19e-04 | 304 | 107 | 8 | int:HSPE1 | |
| Interaction | TPI1 interactions | 2.34e-04 | 307 | 107 | 8 | int:TPI1 | |
| Interaction | RAPGEF2 interactions | 2.43e-04 | 105 | 107 | 5 | int:RAPGEF2 | |
| Interaction | GARRE1 interactions | 2.68e-04 | 167 | 107 | 6 | int:GARRE1 | |
| Interaction | GPM6A interactions | 2.77e-04 | 168 | 107 | 6 | int:GPM6A | |
| Interaction | TRAFD1 interactions | 2.91e-04 | 60 | 107 | 4 | int:TRAFD1 | |
| Interaction | ZFAND2B interactions | 2.91e-04 | 60 | 107 | 4 | int:ZFAND2B | |
| Interaction | HAX1 interactions | 3.04e-04 | 404 | 107 | 9 | int:HAX1 | |
| Interaction | CUL2 interactions | FLNC DNAJB6 CCNF CTNNA1 ASPRV1 DNAJA1 HSPA1A ENO1 HSPA1B ENO2 SNRNP200 | 3.06e-04 | 591 | 107 | 11 | int:CUL2 |
| Interaction | SHANK3 interactions | 3.10e-04 | 496 | 107 | 10 | int:SHANK3 | |
| Interaction | PGM1 interactions | 3.15e-04 | 111 | 107 | 5 | int:PGM1 | |
| Interaction | H2BC12 interactions | 3.22e-04 | 322 | 107 | 8 | int:H2BC12 | |
| Interaction | UNK interactions | 3.27e-04 | 408 | 107 | 9 | int:UNK | |
| Interaction | DNAJB12 interactions | 3.34e-04 | 174 | 107 | 6 | int:DNAJB12 | |
| Interaction | ENO1 interactions | FLNC NEB CCNF STK10 SCG3 H1-1 HSPA1A ENO1 ENO2 ENO3 PCDH7 VCAM1 | 3.45e-04 | 701 | 107 | 12 | int:ENO1 |
| Interaction | CYCS interactions | 3.51e-04 | 247 | 107 | 7 | int:CYCS | |
| Interaction | ZGPAT interactions | 3.55e-04 | 176 | 107 | 6 | int:ZGPAT | |
| Interaction | MBNL1 interactions | 3.69e-04 | 249 | 107 | 7 | int:MBNL1 | |
| Interaction | CSRP2 interactions | 3.74e-04 | 64 | 107 | 4 | int:CSRP2 | |
| Interaction | KCTD13 interactions | FLNC CTTNBP2 SPTA1 DNAJB6 ALDH1L1 ARHGAP35 MDH1 COTL1 LACTB UBA1 OGDHL CTNNA1 HSPA1A PCDH1 ENO2 SNRNP200 PRRC2B CNTN1 | 3.75e-04 | 1394 | 107 | 18 | int:KCTD13 |
| Interaction | CNOT2 interactions | 3.77e-04 | 178 | 107 | 6 | int:CNOT2 | |
| Interaction | SNAP25 interactions | 3.86e-04 | 116 | 107 | 5 | int:SNAP25 | |
| Interaction | EEF1D interactions | 4.03e-04 | 333 | 107 | 8 | int:EEF1D | |
| Interaction | PCMT1 interactions | 4.36e-04 | 256 | 107 | 7 | int:PCMT1 | |
| Interaction | CORO1C interactions | 4.45e-04 | 338 | 107 | 8 | int:CORO1C | |
| Interaction | SLBP interactions | 4.45e-04 | 67 | 107 | 4 | int:SLBP | |
| Interaction | MAP2K5 interactions | 4.51e-04 | 120 | 107 | 5 | int:MAP2K5 | |
| Interaction | EIF3I interactions | 4.56e-04 | 258 | 107 | 7 | int:EIF3I | |
| Interaction | UCHL3 interactions | 4.63e-04 | 185 | 107 | 6 | int:UCHL3 | |
| Interaction | DTWD2 interactions | 4.81e-04 | 29 | 107 | 3 | int:DTWD2 | |
| Interaction | SOD1 interactions | 4.86e-04 | 431 | 107 | 9 | int:SOD1 | |
| Interaction | DLD interactions | 4.92e-04 | 526 | 107 | 10 | int:DLD | |
| Interaction | CCDC50 interactions | 4.98e-04 | 69 | 107 | 4 | int:CCDC50 | |
| Interaction | TLN1 interactions | 5.23e-04 | 264 | 107 | 7 | int:TLN1 | |
| Interaction | HMGCL interactions | 5.55e-04 | 71 | 107 | 4 | int:HMGCL | |
| Interaction | CEBPB interactions | ANXA3 PBDC1 AGPS MDH1 GATAD2B POLR3A MKNK1 MTPN UBA1 SPIN1 GLS H1-5 HTATSF1 DNAJA1 HSPA1A ENO1 SNRNP200 BAG6 | 5.65e-04 | 1443 | 107 | 18 | int:CEBPB |
| Interaction | RNF207 interactions | 5.76e-04 | 7 | 107 | 2 | int:RNF207 | |
| Interaction | CNTRL interactions | 5.79e-04 | 193 | 107 | 6 | int:CNTRL | |
| Interaction | LPP interactions | 5.84e-04 | 127 | 107 | 5 | int:LPP | |
| Interaction | TKT interactions | 5.92e-04 | 353 | 107 | 8 | int:TKT | |
| Interaction | MAP1B interactions | DNAJB6 CCNF DNAJA1 HSPA1A ENO1 HSPA1B ENO3 SNRNP200 BAG6 CNOT3 | 5.94e-04 | 539 | 107 | 10 | int:MAP1B |
| Interaction | NDUFB10 interactions | 5.95e-04 | 194 | 107 | 6 | int:NDUFB10 | |
| Interaction | TARS1 interactions | 6.11e-04 | 195 | 107 | 6 | int:TARS1 | |
| Interaction | SUZ12 interactions | PPID GATAD2B CCNF HTATSF1 ING4 H1-1 CTNNA1 DNAJA1 HSPA1A SNRNP200 BAG6 | 6.27e-04 | 644 | 107 | 11 | int:SUZ12 |
| Interaction | PDLIM5 interactions | 6.38e-04 | 273 | 107 | 7 | int:PDLIM5 | |
| Interaction | FKBP1B interactions | 6.45e-04 | 32 | 107 | 3 | int:FKBP1B | |
| Interaction | ARHGAP40 interactions | 6.45e-04 | 32 | 107 | 3 | int:ARHGAP40 | |
| Interaction | GET3 interactions | 6.50e-04 | 130 | 107 | 5 | int:GET3 | |
| Interaction | TXN interactions | 6.73e-04 | 360 | 107 | 8 | int:TXN | |
| Interaction | PGAM1 interactions | 6.80e-04 | 199 | 107 | 6 | int:PGAM1 | |
| Cytoband | 2p13.3 | 8.54e-05 | 36 | 108 | 3 | 2p13.3 | |
| Cytoband | 1p32-p31 | 1.95e-04 | 9 | 108 | 2 | 1p32-p31 | |
| Cytoband | 6p21.3 | 3.25e-04 | 250 | 108 | 5 | 6p21.3 | |
| Cytoband | Xp22.33 | 1.59e-03 | 25 | 108 | 2 | Xp22.33 | |
| Cytoband | 3q11.2 | 1.72e-03 | 26 | 108 | 2 | 3q11.2 | |
| GeneFamily | Chloride voltage-gated channels | 7.09e-04 | 10 | 73 | 2 | 302 | |
| GeneFamily | Non-clustered protocadherins | 1.03e-03 | 12 | 73 | 2 | 21 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.58e-03 | 57 | 73 | 3 | 1179 | |
| GeneFamily | Heat shock 70kDa proteins | 2.10e-03 | 17 | 73 | 2 | 583 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 2.91e-03 | 20 | 73 | 2 | 1371 | |
| Coexpression | LI_CISPLATIN_RESISTANCE_DN | 2.34e-07 | 33 | 108 | 5 | M10150 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 1.70e-06 | 198 | 108 | 8 | MM17083 | |
| Coexpression | GSE43955_10H_VS_30H_ACT_CD4_TCELL_UP | 1.83e-06 | 200 | 108 | 8 | M9689 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_ENDOTHELIAL_CELL_AGEING | 2.40e-06 | 145 | 108 | 7 | MM3744 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 6.85e-06 | 404 | 108 | 10 | M19488 | |
| Coexpression | MOOTHA_GLUCONEOGENESIS | 7.87e-06 | 31 | 108 | 4 | M13448 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TES ARHGAP35 NEB CSMD3 FSIP2 PIEZO2 NRXN1 RETREG1 OGDHL FAM216A ZFHX3 SCIN PCDH1 PCDH7 PRRC2B CNTN1 | 1.20e-05 | 1106 | 108 | 16 | M39071 |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_UP | 1.97e-05 | 200 | 108 | 7 | M3620 | |
| Coexpression | GSE4142_GC_BCELL_VS_MEMORY_BCELL_UP | 1.97e-05 | 200 | 108 | 7 | M6397 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 1.97e-05 | 200 | 108 | 7 | M5915 | |
| Coexpression | KIM_WT1_TARGETS_UP | 3.32e-05 | 217 | 108 | 7 | M9128 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 5.29e-05 | 318 | 108 | 8 | M41707 | |
| Coexpression | CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP | 6.12e-05 | 239 | 108 | 7 | M4716 | |
| Coexpression | LAMB_CCND1_TARGETS | 7.37e-05 | 20 | 108 | 3 | M2935 | |
| Coexpression | HAY_BONE_MARROW_CD34_POS_MULTILIN | 7.37e-05 | 20 | 108 | 3 | M39188 | |
| Coexpression | MOOTHA_GLYCOLYSIS | 8.57e-05 | 21 | 108 | 3 | M16111 | |
| Coexpression | FAN_OVARY_CL11_MURAL_GRANULOSA_CELL | 9.43e-05 | 444 | 108 | 9 | M41713 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | 1.22e-04 | 568 | 108 | 10 | M4023 | |
| Coexpression | ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP | 1.24e-04 | 186 | 108 | 6 | M3019 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ARHGAP35 PPID TXNL1 RRN3 SPIN1 SCG3 HSPA1A ENO1 HSPA1B ENO2 PCDH7 PRRC2B CDK6 | 1.41e-04 | 946 | 108 | 13 | M39169 |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 1.47e-04 | 121 | 108 | 5 | M12828 | |
| Coexpression | AIZARANI_LIVER_C18_NK_NKT_CELLS_5 | 1.47e-04 | 121 | 108 | 5 | M39120 | |
| Coexpression | GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP | 1.65e-04 | 196 | 108 | 6 | M8135 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM | 1.71e-04 | 67 | 108 | 4 | M1686 | |
| Coexpression | GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_UP | 1.74e-04 | 198 | 108 | 6 | M9571 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 1.79e-04 | 199 | 108 | 6 | M6646 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL | 1.81e-04 | 380 | 108 | 8 | M45714 | |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | 1.83e-04 | 485 | 108 | 9 | M8513 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP | 1.84e-04 | 200 | 108 | 6 | M8614 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN | 1.84e-04 | 200 | 108 | 6 | M5135 | |
| Coexpression | GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN | 1.84e-04 | 200 | 108 | 6 | M3199 | |
| Coexpression | ZHONG_PFC_C2_THY1_POS_OPC | 1.85e-04 | 27 | 108 | 3 | M39097 | |
| Coexpression | TRAVAGLINI_LUNG_NEUROENDOCRINE_CELL | 1.91e-04 | 128 | 108 | 5 | M41658 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 2.07e-04 | 493 | 108 | 9 | M19391 | |
| Coexpression | MOREIRA_RESPONSE_TO_TSA_UP | 2.07e-04 | 28 | 108 | 3 | M15501 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_2B | 2.12e-04 | 389 | 108 | 8 | M4995 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM | 2.14e-04 | 71 | 108 | 4 | MM1210 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 2.21e-04 | 132 | 108 | 5 | MM465 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | 2.50e-04 | 506 | 108 | 9 | M39067 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE | 2.78e-04 | 76 | 108 | 4 | M1685 | |
| Coexpression | BRUECKNER_TARGETS_OF_MIRLET7A3_DN | 2.78e-04 | 76 | 108 | 4 | M11825 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5 | 3.09e-04 | 32 | 108 | 3 | MM1278 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | COL4A1 CFH ANXA3 LAMA4 CFB PIEZO2 SCG3 HSPA1A HSPA1B PCDH7 VCAM1 PROS1 | 3.05e-06 | 453 | 107 | 12 | GSM777067_500 |
| CoexpressionAtlas | kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.08e-06 | 45 | 107 | 5 | gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_k3_1000 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | COL4A1 CFH DSC3 LAMA4 CFB PIEZO2 SCG3 HSPA1A HSPA1B PCDH7 VCAM1 PROS1 | 3.19e-06 | 455 | 107 | 12 | GSM777055_500 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | COL4A1 CFH DSC3 LAMA4 CFB PIEZO2 SCG3 HSPA1A HSPA1B PCDH7 VCAM1 PROS1 | 4.08e-06 | 466 | 107 | 12 | GSM777050_500 |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-3 | 5.04e-05 | 418 | 107 | 10 | GSM605836_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | COL4A1 TES ANXA3 LAMA4 COTL1 STK10 PIEZO2 CRYBG3 GNGT2 PCDH1 PROS1 | 6.70e-05 | 523 | 107 | 11 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k4_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.LuLN, MHCII+ CD11c+ CD8- CD11b+ CD103-, Lymph Node, avg-3 | 9.89e-05 | 366 | 107 | 9 | GSM854255_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN2B.Th, Lin-/lo CD25hi CD44+ cKitint, Thymus, avg-2 | 1.03e-04 | 92 | 107 | 5 | GSM791141_100 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | COL4A1 ANXA3 LAMA4 CFB PIEZO2 HSPA1A HSPA1B PCDH1 VCAM1 PROS1 | 1.04e-04 | 456 | 107 | 10 | GSM777032_500 |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.LuLN, MHCII+ CD11c+ CD8- CD11b- CD103+, Lymph Node, avg-3 | 1.21e-04 | 376 | 107 | 9 | GSM854243_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-IIint.Bl, CD115+ B220- CD43- Ly6C- MHCIIint, Blood, avg-5 | 1.93e-04 | 400 | 107 | 9 | GSM605886_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II-.Bl, CD115+ B220- CD43- Ly6C- MHCII-, Blood, avg-3 | 2.00e-04 | 402 | 107 | 9 | GSM605883_500 | |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45-EpCAm+Ly51-MHCIIhi, Thymus, avg-1 | 2.35e-04 | 411 | 107 | 9 | GSM854302_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.IIhilang+103-11b+.SLN, MHCIIhi CD11c+ Langerin+ CD103- CD11b+, Lymph Node, avg-3 | 2.35e-04 | 411 | 107 | 9 | GSM538271_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_500 | 2.53e-04 | 415 | 107 | 9 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_ReproVasc_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.73e-04 | 514 | 107 | 10 | gudmap_dev gonad_e11.5_M_ReproVasc_Flk_k4_1000 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#1_top-relative-expression-ranked_500 | 3.33e-04 | 27 | 107 | 3 | gudmap_kidney_adult_CortVasc_Tie2_k1_500 | |
| CoexpressionAtlas | e10.5_NeuroEpith_LateralEmin_top-relative-expression-ranked_500_5 | 3.72e-04 | 6 | 107 | 2 | Facebase_ST1_e10.5_NeuroEpith_LateralEmin_500_5 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | CFH CTTNBP2 ARHGAP15 SLFN12L PIEZO2 CRYBG3 HSPA1A HSPA1B VCAM1 CNTN1 | 3.85e-11 | 190 | 108 | 10 | 62a3ec1ae0829602b0569cc051210551644f1d46 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-10 | 184 | 108 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-10 | 184 | 108 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-10 | 184 | 108 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-09 | 198 | 108 | 9 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.07e-08 | 199 | 108 | 8 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.80e-07 | 194 | 108 | 7 | 421344cc4b601d9745fa72d0af3124dab11d1d27 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.14e-07 | 196 | 108 | 7 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-07 | 196 | 108 | 7 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-07 | 196 | 108 | 7 | e874aa82a20bb59582c8cd7f8d30b2ed02903a85 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.51e-07 | 198 | 108 | 7 | 0f4052a59c6bd89dab637d6ef1214460d6cbcf55 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.70e-07 | 199 | 108 | 7 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.70e-07 | 199 | 108 | 7 | d2f6d04045e11d81c979949d0f5c2f7380f33400 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.70e-07 | 199 | 108 | 7 | 6a0df9a2f30480043f9c1d7fbdede17eb0910cac | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.89e-07 | 200 | 108 | 7 | c5d818203bef80ff97c2e0158cf61970673dd258 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-maDC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-06 | 153 | 108 | 6 | b03375c54aa701817c0fc2c3fef32b870169e697 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-06 | 153 | 108 | 6 | 18bd770a18e642581a6df144d47184c1ac383713 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-06 | 157 | 108 | 6 | 0966e347f8d32b13f8a3b3afba3f64637c69cdf9 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-06 | 157 | 108 | 6 | 6ebfedd91d62c6d4aa8f046657a899a279f82ba2 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-06 | 170 | 108 | 6 | 8e774af244cfe787fa0ea2b6be0c3c2d00bfe4fc | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-06 | 170 | 108 | 6 | f5140eb9313c0d1bb31f8a761d9c062c56733a61 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.83e-06 | 171 | 108 | 6 | 92cd1d7ec5bc0a77f81b915d237fac4075ba01e3 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.96e-06 | 172 | 108 | 6 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.10e-06 | 173 | 108 | 6 | 6d29e142d043dfd1ed442812358ac463b63b5e3f | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-06 | 175 | 108 | 6 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.15e-06 | 180 | 108 | 6 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | (0)_Normal/No_Treatment|World / Stress and Cell class | 5.31e-06 | 181 | 108 | 6 | 4077282c45a37403f47e8d1b9ac102e6b1ba2cf9 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 5.84e-06 | 184 | 108 | 6 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.21e-06 | 186 | 108 | 6 | 7812ed80d2378aca9957ef22fc3c8fb7fb58434b | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.21e-06 | 186 | 108 | 6 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-06 | 188 | 108 | 6 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-06 | 188 | 108 | 6 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.81e-06 | 189 | 108 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | Globus_pallidus-Endothelial|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.81e-06 | 189 | 108 | 6 | ad7dc9d25edd68fb624380a082c389fe7d640e7d | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 6.81e-06 | 189 | 108 | 6 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | (1)_T_CD8_gd|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.81e-06 | 189 | 108 | 6 | 62eda4bcfd21d5025ac676d524994ede22721c1d | |
| ToppCell | 343B-Myeloid-Dendritic-cDC2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 6.95e-06 | 109 | 108 | 5 | 6e90d04c5094c7410d667dae80de3279bddd24bd | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-06 | 190 | 108 | 6 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.45e-06 | 192 | 108 | 6 | 3fc7a661ef39286abfd82ed8ab580011f01cb8fd | |
| ToppCell | E15.5-Endothelial|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.45e-06 | 192 | 108 | 6 | 88cc7f14d031a0613d032eb01c93e88c72d3938f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.67e-06 | 193 | 108 | 6 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.67e-06 | 193 | 108 | 6 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.67e-06 | 193 | 108 | 6 | 46d5d1f8150ebbc7f1941b96ab184491e5c1210b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.67e-06 | 193 | 108 | 6 | d994b2f2707877288f88cab7cd6002ef91962c50 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.90e-06 | 194 | 108 | 6 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.90e-06 | 194 | 108 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | droplet-Kidney-KIDNEY-1m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 194 | 108 | 6 | 837cee7e6147d92a2f4b86f1ed761a9bfe65b61d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.90e-06 | 194 | 108 | 6 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-06 | 195 | 108 | 6 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-06 | 195 | 108 | 6 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | Cerebellum-Endothelial|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.14e-06 | 195 | 108 | 6 | 2192fd9b4682054776f0716933aed5a4a9412657 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.14e-06 | 195 | 108 | 6 | 9fea1ddb68da83ca43dd8006c9e51295b1817f0e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-06 | 195 | 108 | 6 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-06 | 195 | 108 | 6 | e94bac6a5c788ee160d7feaf2a3c512a3691f995 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-06 | 195 | 108 | 6 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.38e-06 | 196 | 108 | 6 | 9afd0a7135028a446f06bb68f334e79b8f171b45 | |
| ToppCell | Epithelial-Epithelial-A_(AT1)|Epithelial / shred on cell class and cell subclass (v4) | 8.38e-06 | 196 | 108 | 6 | 41b21a18125cc95bc8adde3369e4abd029cf137d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-06 | 196 | 108 | 6 | 023477a499a2c190f363cfdbc9d9c646733a6541 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.38e-06 | 196 | 108 | 6 | 4924a36a81d62863c1004b8c76f8096a1f89c548 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.38e-06 | 196 | 108 | 6 | 85507488f83d8f71b3ee2ad5e5aa0b6ad6193873 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-06 | 196 | 108 | 6 | 3cb74f1a333a82cac2b459f2f1517e2acf22b5fd | |
| ToppCell | 368C|World / Donor, Lineage, Cell class and subclass (all cells) | 8.62e-06 | 197 | 108 | 6 | f41211923938e5d7bfe6bf24f604ab386f17ef10 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-gdT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-06 | 197 | 108 | 6 | b803c07072a7860497d07a3be358a28a24359cbf | |
| ToppCell | Fibroblast|World / shred by cell class for bronchial biopsy | 8.62e-06 | 197 | 108 | 6 | 8bf9846228b6b6721b10375fe54a2fb389ff64a6 | |
| ToppCell | Mild|World / Condition, Lineage, Cell class and cell subclass | 8.62e-06 | 197 | 108 | 6 | 476b0d0389f9fcd4614f6bb1f494281f467f6730 | |
| ToppCell | (4)_Endothelial_cells-(41)_EC-arteriolar|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.62e-06 | 197 | 108 | 6 | 482e3f8926880afed88ed37553ed2b5ed58b8c99 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.62e-06 | 197 | 108 | 6 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.62e-06 | 197 | 108 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.62e-06 | 197 | 108 | 6 | b8dc192fc98428bbb701cc2ea57fc8ad93397785 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.62e-06 | 197 | 108 | 6 | 5a63c2b824c7d0dbbc706e408459c9b9fe65daaa | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.87e-06 | 198 | 108 | 6 | e9f434bfd072e590fe44d518057ee5aa653038f3 | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.13e-06 | 199 | 108 | 6 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 9.13e-06 | 199 | 108 | 6 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-06 | 199 | 108 | 6 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.13e-06 | 199 | 108 | 6 | a272c54baf8de59c0f259e6498d144a0de8d8924 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 9.13e-06 | 199 | 108 | 6 | ca970114b5aef4518ce580897a62ac88688b2671 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Transitional_AT2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.13e-06 | 199 | 108 | 6 | cd581d7330b471431ef427f8a4f5be553f70e068 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.13e-06 | 199 | 108 | 6 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-06 | 199 | 108 | 6 | c972d3036151403f26fa9d6271520639c281ab84 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.13e-06 | 199 | 108 | 6 | 6139687a3a5025cb98da4dba0183f95fcae3dc61 | |
| ToppCell | H1299-uninfected|H1299 / Cell line, Condition and Strain | 9.13e-06 | 199 | 108 | 6 | 4594eb3e6d29285155df8dfd322ccf532d7e94b8 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.13e-06 | 199 | 108 | 6 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.13e-06 | 199 | 108 | 6 | a843bdfcb58bec5e2a94a5ec9d5b8c5e4aef15d2 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.40e-06 | 200 | 108 | 6 | 1801f10910aea899269025f24d1ca2d62168c6a6 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.40e-06 | 200 | 108 | 6 | c800f20adedf4ca736c740510889e92d8bf0ba44 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Cortical_neuron|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 9.40e-06 | 200 | 108 | 6 | 458fb0f40c1720f1cacedf78c40bd059692bfc62 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.40e-06 | 200 | 108 | 6 | 93c1db92e0e456101f7895867fc8a1fe45298347 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.40e-06 | 200 | 108 | 6 | 874ae350634936c7efd8b44895d20935a1747acd | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.40e-06 | 200 | 108 | 6 | c0ea7cbc9d5e999530888145ce9e4c232fc874de | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.40e-06 | 200 | 108 | 6 | 3be373e9a30e19334e4709e2819fb83cc777d104 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.40e-06 | 200 | 108 | 6 | bf50e30d5cafb71c567e89580f62084d2f894170 | |
| ToppCell | Kidney|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 9.40e-06 | 200 | 108 | 6 | 1f99afa1f3c32a2a9cfb4ad33ff4d404e34fac63 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.40e-06 | 200 | 108 | 6 | d87ca8b0007b1743ae23ebd3c7e8aa7f53e39335 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.40e-06 | 200 | 108 | 6 | 5e5ad07679d5dd2ca80249bce9aaf4a95d42187b | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.40e-06 | 200 | 108 | 6 | 46d0ae385e67030bfaf7062bb6b43da5db05b33a | |
| ToppCell | Lung_Parenchyma|World / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.67e-06 | 201 | 108 | 6 | 91ec5eebe93a3c7b1a33c27e5da949b123b676a8 | |
| ToppCell | Striatum-Macroglia-CSF_related-EPENDYMAL-Ependyma_Ccdc153.Ccdc153_(Ccdc153)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.82e-06 | 117 | 108 | 5 | 26dec09112532f351fb7a2202bae84c365707b40 | |
| ToppCell | Striatum-Macroglia-CSF_related-EPENDYMAL-Ependyma_Ccdc153.Ccdc153_(Ccdc153)|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.82e-06 | 117 | 108 | 5 | db053c874e6739052dff1f91643e51b306236237 | |
| ToppCell | Striatum-Macroglia-CSF_related-EPENDYMAL-Ependyma_Ccdc153.Ccdc153_(Ccdc153)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.82e-06 | 117 | 108 | 5 | 80780223502d18f0d86a29ff3cb74aa8235103c7 | |
| ToppCell | Striatum-Macroglia-CSF_related-EPENDYMAL|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.82e-06 | 117 | 108 | 5 | 40889f4a387846abbf54469cc4faf616bfe348d0 | |
| Drug | CPEP | 1.60e-08 | 7 | 107 | 4 | CID000360637 | |
| Drug | N-succinylphenylglycine | 1.01e-07 | 3 | 107 | 3 | CID000448582 | |
| Drug | AC1MOUJL | 1.01e-07 | 3 | 107 | 3 | CID003400924 | |
| Drug | C03356 | 1.01e-07 | 3 | 107 | 3 | CID000439988 | |
| Drug | 3-bromo-2-(bromomethyl)propionic acid | 1.01e-07 | 3 | 107 | 3 | CID000318915 | |
| Drug | C04309 | 1.01e-07 | 3 | 107 | 3 | CID000440293 | |
| Drug | 2,3-diketo-1-phosphohexane | 1.01e-07 | 3 | 107 | 3 | CID000192519 | |
| Drug | dimethyl chlorophosphate | 4.02e-07 | 4 | 107 | 3 | CID000101863 | |
| Drug | [2-(oxidoamino)-2-oxoethyl]phosphonic acid | 4.02e-07 | 4 | 107 | 3 | CID011969443 | |
| Drug | 3-aminoenolpyruvate-2-phosphate | 4.02e-07 | 4 | 107 | 3 | CID003037152 | |
| Drug | 2-ptz | 4.02e-07 | 4 | 107 | 3 | CID000445375 | |
| Drug | tricyclohexylammonium | 4.02e-07 | 4 | 107 | 3 | CID000226271 | |
| Drug | N-methylacrylamide | 1.00e-06 | 5 | 107 | 3 | CID000014471 | |
| Drug | AC1L1CAI | 1.00e-06 | 5 | 107 | 3 | CID000000145 | |
| Drug | tartronate semialdehyde phosphate | 1.00e-06 | 5 | 107 | 3 | CID000151938 | |
| Drug | 2-phospho-3-butenoic acid | 1.00e-06 | 5 | 107 | 3 | CID000191423 | |
| Drug | 1-Pdmsp | 1.00e-06 | 5 | 107 | 3 | CID000000561 | |
| Drug | dimidium | 2.00e-06 | 6 | 107 | 3 | CID000068207 | |
| Drug | Z(2-Cl)-OSu | 2.00e-06 | 6 | 107 | 3 | CID000580665 | |
| Drug | 4-(N,N-dimethylamino)cinnamoyl-CoA | 2.00e-06 | 6 | 107 | 3 | CID000445461 | |
| Drug | N-tert-butylacrylamide | 3.48e-06 | 7 | 107 | 3 | CID000007877 | |
| Drug | glycidol phosphate | 3.48e-06 | 7 | 107 | 3 | CID000152659 | |
| Drug | lavendustin C6 | 3.48e-06 | 7 | 107 | 3 | CID000126839 | |
| Drug | hydroxymalonate | 3.81e-06 | 23 | 107 | 4 | CID000000044 | |
| Drug | beta-ketoadipate | 5.00e-06 | 53 | 107 | 5 | CID000000093 | |
| Drug | macrophomate | 5.56e-06 | 8 | 107 | 3 | CID010889109 | |
| Drug | AC1L19IJ | 8.30e-06 | 9 | 107 | 3 | CID000000562 | |
| Drug | AC1L1A4W | 8.30e-06 | 9 | 107 | 3 | CID000000837 | |
| Drug | LG 5 | 9.28e-06 | 60 | 107 | 5 | CID011840957 | |
| Drug | pyrene-4,5-dione | 1.18e-05 | 10 | 107 | 3 | CID000160814 | |
| Drug | L-fuconic acid | 1.18e-05 | 10 | 107 | 3 | CID000345732 | |
| Drug | phosphoenolthiopyruvate | 1.18e-05 | 10 | 107 | 3 | CID000194910 | |
| Drug | xylonate | 1.18e-05 | 10 | 107 | 3 | CID000010264 | |
| Drug | CO(2 | 1.19e-05 | 378 | 107 | 10 | CID000000280 | |
| Drug | 1-Naphthylisothiocyanate | COL4A1 CFH TES ANXA3 MDH1 COTL1 TXNL1 STK10 GLS DNAJA1 HSPA1A HSPA1B GNGT2 VCAM1 PROS1 | 1.38e-05 | 871 | 107 | 15 | ctd:D015058 |
| Drug | LG61 | 2.15e-05 | 12 | 107 | 3 | CID000520177 | |
| Drug | AC1L18ZV | 2.15e-05 | 12 | 107 | 3 | CID000000329 | |
| Drug | B-43 | 3.54e-05 | 14 | 107 | 3 | CID006603792 | |
| Drug | Hecameg | 3.54e-05 | 14 | 107 | 3 | CID002733955 | |
| Drug | Metolazone [17560-51-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.84e-05 | 195 | 107 | 7 | 5392_UP | |
| Drug | Metronidazole [443-48-1]; Up 200; 23.4uM; MCF7; HT_HG-U133A | 4.10e-05 | 197 | 107 | 7 | 1503_UP | |
| Drug | Nystatine [1400-61-9]; Down 200; 4.4uM; HL60; HT_HG-U133A | 4.23e-05 | 198 | 107 | 7 | 2500_DN | |
| Drug | pipemidic acid | 4.41e-05 | 15 | 107 | 3 | CID000004831 | |
| Drug | 1 IN | 4.41e-05 | 15 | 107 | 3 | CID000449311 | |
| Drug | Freon 22 | 5.40e-05 | 16 | 107 | 3 | CID000006372 | |
| Drug | sodium tripolyphosphate | 5.42e-05 | 44 | 107 | 4 | CID000024455 | |
| Drug | oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine | 5.48e-05 | 141 | 107 | 6 | ctd:C472349 | |
| Drug | norfloxacin | 5.92e-05 | 45 | 107 | 4 | CID000004539 | |
| Drug | 2-PE | 6.54e-05 | 17 | 107 | 3 | CID000004867 | |
| Drug | Benzene | EGLN2 TRAF3 AKAP17A ANXA3 PBDC1 DESI2 MTPN CCNF PTPRE HSPA1A HSPA1B VCAM1 FILIP1L CDK6 | 7.48e-05 | 892 | 107 | 14 | ctd:D001554 |
| Drug | N,N-Dichlorourethane | 7.82e-05 | 18 | 107 | 3 | CID000026195 | |
| Drug | o-succinylbenzoic acid | 7.82e-05 | 18 | 107 | 3 | CID000000955 | |
| Drug | AC1L1A7Z | 7.82e-05 | 18 | 107 | 3 | CID000000874 | |
| Drug | Thiophosphonoacetic Acid | 9.08e-05 | 96 | 107 | 5 | CID005459392 | |
| Drug | purpurin-18 | 9.26e-05 | 19 | 107 | 3 | CID005489047 | |
| Drug | AC1L2YVP | 9.26e-05 | 19 | 107 | 3 | CID000080135 | |
| Drug | histidinol phosphate | 9.26e-05 | 19 | 107 | 3 | CID000000845 | |
| Drug | Air Pollutants | CFH CTTNBP2 ANXA3 DNAJB6 NEB COTL1 GATAD2B PIEZO2 TRANK1 GLS ING4 MARCHF4 HSPA1A VCAM1 | 1.00e-04 | 917 | 107 | 14 | ctd:D000393 |
| Drug | enoxacin | 1.09e-04 | 20 | 107 | 3 | CID000003229 | |
| Drug | BE 51 | 1.09e-04 | 20 | 107 | 3 | CID000061972 | |
| Drug | Azetidinecarboxylic Acid | 1.30e-04 | 4 | 107 | 2 | ctd:D001383 | |
| Drug | phosphonopyruvate | 1.31e-04 | 55 | 107 | 4 | CID000439811 | |
| Drug | Acth(11-24) | 1.46e-04 | 22 | 107 | 3 | CID003037130 | |
| Drug | dibenzo(a,l)pyrene | 1.55e-04 | 326 | 107 | 8 | ctd:C041517 | |
| Drug | U285 | 1.58e-04 | 108 | 107 | 5 | CID000009475 | |
| Drug | 2-phenylacetylenesulfonamide | 2.17e-04 | 5 | 107 | 2 | ctd:C545747 | |
| Drug | aloenin A | 2.17e-04 | 5 | 107 | 2 | CID000162305 | |
| Drug | 2-Methyl-4-chlorophenoxyacetic Acid | 2.17e-04 | 5 | 107 | 2 | ctd:D008456 | |
| Drug | pefloxacin | 2.43e-04 | 26 | 107 | 3 | CID000051081 | |
| Drug | 6-[4-[(4-ethyl-2,3-dihydropyrazin-1-yl)methyl]phenyl]-N-[(1R)-1-phenylethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | 2.43e-04 | 26 | 107 | 3 | CID016040258 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 2.50e-04 | 186 | 107 | 6 | 5566_UP | |
| Drug | radicicol; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.58e-04 | 187 | 107 | 6 | 953_UP | |
| Drug | Methamphetamine | FLNC ANXA3 SYT2 GATAD2B LACTB MTPN UBA1 CLCNKB SYNJ2 GLS OGDHL DNAJA1 HSPA1A ENO1 PCDH1 ENO2 CDK6 | 2.80e-04 | 1401 | 107 | 17 | ctd:D008694 |
| Drug | Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.89e-04 | 191 | 107 | 6 | 3582_UP | |
| Drug | AC1Q6RZ4 | 2.90e-04 | 123 | 107 | 5 | CID000000719 | |
| Drug | Nimodipine [66085-59-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.05e-04 | 193 | 107 | 6 | 5421_UP | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Up 200; 16uM; MCF7; HT_HG-U133A | 3.05e-04 | 193 | 107 | 6 | 6100_UP | |
| Drug | Beta-sistosterol [83-46-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.05e-04 | 193 | 107 | 6 | 4154_DN | |
| Drug | Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 3.14e-04 | 194 | 107 | 6 | 4163_DN | |
| Drug | 5 alpha-ergostane | 3.24e-04 | 6 | 107 | 2 | CID000164641 | |
| Drug | polaprezinc | 3.24e-04 | 6 | 107 | 2 | ctd:C061957 | |
| Drug | geranylgeranylacetone | 3.24e-04 | 6 | 107 | 2 | ctd:C031049 | |
| Drug | Arcaine sulfate [14923-17-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 4974_UP | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 3849_DN | |
| Drug | Estropipate [7280-37-7]; Down 200; 9.2uM; PC3; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 4472_DN | |
| Drug | Colistin sulfate [1264-72-8]; Down 200; 3uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 2851_DN | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 5619_DN | |
| Drug | estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 5910_UP | |
| Drug | Pheniramine maleate [132-20-7]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 4130_DN | |
| Drug | PF-00539745-00 [351321-33-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.31e-04 | 196 | 107 | 6 | 5974_DN | |
| Drug | Glu-Ala | 3.37e-04 | 29 | 107 | 3 | CID000100098 | |
| Drug | tetrahydroaldosterone-3-glucuronide | 3.37e-04 | 29 | 107 | 3 | CID000167918 | |
| Drug | 1-phenylpentan-3-amine | 3.37e-04 | 29 | 107 | 3 | CID005195771 | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 3838_DN | |
| Drug | Xamoterol hemifumarate [73210-73-8]; Down 200; 5uM; HL60; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 3064_DN | |
| Drug | Norfloxacin [70458-96-7]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 3.40e-04 | 197 | 107 | 6 | 2253_UP | |
| Drug | Solasodine [126-17-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 6025_UP | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 7489_DN | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; HL60; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 2182_UP | |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; PC3; HT_HG-U133A | 3.50e-04 | 198 | 107 | 6 | 5064_UP | |
| Disease | Bartter disease type 4B | 1.25e-05 | 2 | 105 | 2 | cv:C4310805 | |
| Disease | Bartter disease type 3 (implicated_via_orthology) | 1.25e-05 | 2 | 105 | 2 | DOID:0110144 (implicated_via_orthology) | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 1.25e-05 | 2 | 105 | 2 | 613090 | |
| Disease | BARTTER SYNDROME, TYPE 4B | 1.25e-05 | 2 | 105 | 2 | C2751312 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 1.25e-05 | 2 | 105 | 2 | C4310805 | |
| Disease | Bartter disease type 4b (is_implicated_in) | 1.25e-05 | 2 | 105 | 2 | DOID:0110146 (is_implicated_in) | |
| Disease | Bartter disease (implicated_via_orthology) | 1.25e-05 | 2 | 105 | 2 | DOID:445 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 2.61e-05 | 48 | 105 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | cysteine and glycine-rich protein 2 measurement | 3.75e-05 | 3 | 105 | 2 | EFO_0802444 | |
| Disease | complement C3D fragment measurement | 3.75e-05 | 3 | 105 | 2 | EFO_0020277 | |
| Disease | sorting nexin-7 measurement | 7.49e-05 | 4 | 105 | 2 | EFO_0803094 | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 1.25e-04 | 5 | 105 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | interleukin-10 receptor subunit beta measurement | 1.25e-04 | 5 | 105 | 2 | EFO_0020489 | |
| Disease | probable ATP-dependent RNA helicase DHX58 measurement | 1.25e-04 | 5 | 105 | 2 | EFO_0802901 | |
| Disease | spontaneous coronary artery dissection | 1.83e-04 | 31 | 105 | 3 | EFO_0010820 | |
| Disease | thymidine kinase, cytosolic measurement | 1.86e-04 | 6 | 105 | 2 | EFO_0020773 | |
| Disease | NKG2-E type II integral membrane protein measurement | 1.86e-04 | 6 | 105 | 2 | EFO_0801842 | |
| Disease | aurora kinase B measurement | 1.86e-04 | 6 | 105 | 2 | EFO_0020169 | |
| Disease | transcription factor AP-1 measurement | 1.86e-04 | 6 | 105 | 2 | EFO_0021909 | |
| Disease | CCAAT/enhancer-binding protein beta measurement | 1.86e-04 | 6 | 105 | 2 | EFO_0021905 | |
| Disease | Bartter syndrome | 1.86e-04 | 6 | 105 | 2 | cv:C0004775 | |
| Disease | DNA-binding protein SATB2 measurement | 1.86e-04 | 6 | 105 | 2 | EFO_0802484 | |
| Disease | mast/stem cell growth factor receptor kit measurement | 2.60e-04 | 7 | 105 | 2 | EFO_0020554 | |
| Disease | Glomerulonephritis, Membranoproliferative | 2.60e-04 | 7 | 105 | 2 | C0017662 | |
| Disease | vascular cell adhesion protein 1 measurement | 2.60e-04 | 7 | 105 | 2 | EFO_0020846 | |
| Disease | 3-hydroxy-1-methylpropylmercapturic acid measurement | 2.71e-04 | 352 | 105 | 7 | EFO_0007015 | |
| Disease | anterior uveitis (is_implicated_in) | 3.46e-04 | 8 | 105 | 2 | DOID:1407 (is_implicated_in) | |
| Disease | PH and SEC7 domain-containing protein 1 measurement | 3.46e-04 | 8 | 105 | 2 | EFO_0803302 | |
| Disease | atypical hemolytic-uremic syndrome (is_implicated_in) | 3.46e-04 | 8 | 105 | 2 | DOID:0080301 (is_implicated_in) | |
| Disease | serum gamma-glutamyl transferase measurement | COL4A1 TRAF3 IKZF2 S100G ANXA3 ARHGAP35 CSMD3 TRANK1 CLCNKB SYNJ2 CDK6 | 4.18e-04 | 914 | 105 | 11 | EFO_0004532 |
| Disease | complement C1q and tumor necrosis factor-related protein 9A measurement | 4.44e-04 | 9 | 105 | 2 | EFO_0803293 | |
| Disease | C3 glomerulopathy | 4.44e-04 | 9 | 105 | 2 | C4087273 | |
| Disease | Atypical hemolytic-uremic syndrome | 4.44e-04 | 9 | 105 | 2 | cv:C2931788 | |
| Disease | Hemolytic-uremic syndrome | 4.44e-04 | 9 | 105 | 2 | cv:C0019061 | |
| Disease | complement factor B measurement | 4.44e-04 | 9 | 105 | 2 | EFO_0008096 | |
| Disease | Major depression, single episode | 4.44e-04 | 9 | 105 | 2 | C0024517 | |
| Disease | tumor necrosis factor ligand superfamily member 14 measurement | 4.44e-04 | 9 | 105 | 2 | EFO_0010613 | |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 5.54e-04 | 10 | 105 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | Atypical Hemolytic Uremic Syndrome | 5.54e-04 | 10 | 105 | 2 | C2931788 | |
| Disease | interleukin-37 measurement | 5.54e-04 | 10 | 105 | 2 | EFO_0020506 | |
| Disease | wet macular degeneration | 1.11e-03 | 14 | 105 | 2 | EFO_0004683 | |
| Disease | unipolar depression | CFH CTTNBP2 CSMD3 CFB SLFN12L PIEZO2 NRXN1 H1-5 ZFHX3 PCDH1 SNRNP200 CNTN1 | 1.21e-03 | 1206 | 105 | 12 | EFO_0003761 |
| Disease | Cerebrovascular accident | 1.42e-03 | 62 | 105 | 3 | C0038454 | |
| Disease | diastolic blood pressure, body mass index | 1.46e-03 | 16 | 105 | 2 | EFO_0004340, EFO_0006336 | |
| Disease | neutrophil percentage of leukocytes | 1.54e-03 | 610 | 105 | 8 | EFO_0007990 | |
| Disease | lupus nephritis (is_marker_for) | 1.65e-03 | 17 | 105 | 2 | DOID:0080162 (is_marker_for) | |
| Disease | Liver Cirrhosis, Experimental | 1.80e-03 | 774 | 105 | 9 | C0023893 | |
| Disease | body fat percentage | 1.83e-03 | 488 | 105 | 7 | EFO_0007800 | |
| Disease | Age-related macular degeneration | 1.85e-03 | 18 | 105 | 2 | cv:C0242383 | |
| Disease | lymphocyte count | COL4A1 TRAF3 ARHGAP15 AKAP17A PCDHGA9 SPTA1 PPID SLC35D1 SLFN12L HSPA1A HSPA1B VCAM1 CDK6 | 2.09e-03 | 1464 | 105 | 13 | EFO_0004587 |
| Disease | systemic lupus erythematosus | 2.23e-03 | 799 | 105 | 9 | MONDO_0007915 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 2.26e-03 | 801 | 105 | 9 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | glaucoma (is_marker_for) | 2.29e-03 | 20 | 105 | 2 | DOID:1686 (is_marker_for) | |
| Disease | coagulation factor measurement | 2.29e-03 | 20 | 105 | 2 | EFO_0004634 | |
| Disease | tissue factor measurement | 2.52e-03 | 21 | 105 | 2 | EFO_0010623 | |
| Disease | diastolic blood pressure, systolic blood pressure | 2.74e-03 | 670 | 105 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | complement factor H-like 1 protein measurement | 2.77e-03 | 22 | 105 | 2 | EFO_0600092 | |
| Disease | Carcinoma, Pancreatic Ductal | 3.29e-03 | 24 | 105 | 2 | C0887833 | |
| Disease | suicidal ideation, suicide behaviour | 3.29e-03 | 24 | 105 | 2 | EFO_0004320, EFO_0007623 | |
| Disease | longevity | 3.52e-03 | 284 | 105 | 5 | EFO_0004300 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TKKALKYFEEGLQDG | 161 | Q7Z4L5 | |
| GFKVNYKEIEKESCG | 651 | Q7Z407 | |
| NTYQKDAEGDIGKAE | 1716 | Q68DQ2 | |
| LQDDKKLQEYNVGGK | 66 | P46379 | |
| KKALAAAGYDVEKNN | 66 | Q02539 | |
| QAAYGKELKDDLKGD | 61 | P12429 | |
| EGAYGKVFKARDLKN | 21 | Q00534 | |
| LLNGNVKEKTKEEYG | 636 | P08603 | |
| SDAKKRELYDKGGEQ | 56 | P31689 | |
| IKDKYGKDATNVGDE | 196 | P09104 | |
| EKIVEELGKEYKGNA | 86 | Q9BSY9 | |
| KAYSKEGLGLAQKVD | 101 | O75175 | |
| AQVQEKGDFATKGEK | 246 | P02462 | |
| YKDGFDLNKGIEAKI | 91 | Q14627 | |
| FLDEDLKVAGKYKGN | 791 | Q5TC82 | |
| AEKLGAAAGFNYKKE | 181 | Q53FA7 | |
| IDELYESAKKQSGGK | 231 | O94925 | |
| ESAKKQSGGKVADYI | 236 | O94925 | |
| YIKNGDKKGSCERDA | 646 | P00751 | |
| YTVEQLKGKALKNEG | 301 | Q8N635 | |
| DGYKEKNKFIAAQGP | 196 | P23469 | |
| VNGLEKGALEQEAKY | 241 | P55771 | |
| GRSQDYINDAAKKAK | 386 | P21941 | |
| GKKKNDFEQGELYLR | 281 | P83111 | |
| GSDSEIGYKKKIDNA | 5601 | Q5CZC0 | |
| KLQGKEVGVYEALKD | 201 | P40925 | |
| NDGDKPKVQVSYKGE | 96 | P0DMV9 | |
| KAEQFYRGDAQGKKV | 376 | Q9ULD0 | |
| ASDLDEGINGKVAYK | 266 | Q9Y5G4 | |
| EAKSGYQAGKKETKD | 881 | Q08174 | |
| SKNKNGYEAGKKDHE | 906 | O60245 | |
| KAVYISVQDKEGEKG | 156 | Q9BVG4 | |
| AAGKGDLKLYAQDAD | 696 | Q14315 | |
| KVYGQAEAAIGKSKD | 856 | Q0VF49 | |
| KQDGSGVKGYEEKLN | 66 | Q8WXI9 | |
| ADAKDNSIKVYQGLK | 106 | P0CG21 | |
| GDQGKSKGKEEYIAT | 271 | Q9ULB1 | |
| KGSLKDIYKVFNGEG | 451 | Q9UKS7 | |
| KLYKDNQGNLKGDGL | 171 | O43719 | |
| KRDIYDKYGKEGLNG | 61 | O75190 | |
| IKEKYGKDATNVGDE | 196 | P06733 | |
| KKALAAGGYDVEKNN | 66 | P16401 | |
| KSELKKAGGANYDAQ | 126 | Q14019 | |
| EAAKNGNEKEVKEYA | 406 | P35221 | |
| KENLAVGSKINGYKA | 481 | Q14574 | |
| EKGNFEAAVKLGIAY | 96 | P41002 | |
| KAGKEIKEYVEAQAG | 31 | O14610 | |
| ALQRDYEAGAGDKEK | 86 | Q8WZ74 | |
| LQDIKEKISKGEYGN | 351 | Q4L180 | |
| QVKVKAFNNKGDGPY | 781 | Q12860 | |
| VREKGSGKQNKDLYE | 611 | Q96BJ8 | |
| NYDKTKDLEDQKAGG | 316 | Q9P2E8 | |
| IKAKYGKDATNVGDE | 196 | P13929 | |
| AAAKDKYQLASGQKG | 381 | Q96KS0 | |
| NDGDKPKVQVSYKGE | 96 | P0DMV8 | |
| QNSKGSDRIKDGYKV | 56 | Q8WUB2 | |
| DKSENGEAYQRKKAA | 151 | Q8N1S5 | |
| KNKKIYDGGARTEDE | 236 | P56856 | |
| AYGKCKEFGDDKVQL | 71 | Q9UNL4 | |
| KGIKVQSVDKQYNDG | 1296 | Q16363 | |
| NGKEYAVKIIEKQAG | 71 | Q9BUB5 | |
| AAKGILNDNIKDYVG | 291 | Q6PCB5 | |
| KDVCYVDGKVDNGKT | 326 | Q9NYV6 | |
| DYDKLGKNEAIGKIF | 361 | Q8N9I0 | |
| KDAGVYECESKNKVG | 661 | P19320 | |
| EQFVKKYKSEALGVG | 176 | Q9UGI8 | |
| NGYEDLKNKKVRFVG | 171 | Q96Q11 | |
| EKEVIKGQYGKLTDA | 46 | O15056 | |
| LEDEKSGKDGIKQYA | 1166 | Q8NE09 | |
| LKLDFGIGEYINQKK | 251 | Q9H6L5 | |
| KGASQEEEKGAEYVA | 556 | Q9Y6U3 | |
| IAAKQRLKDAGYGEK | 911 | Q8IZX4 | |
| TVNYKGKGSAKEIQE | 376 | Q5T2S8 | |
| KEYDQALADLKKAQG | 321 | Q08752 | |
| GADGKQKGVDKEFFL | 566 | Q9BQS7 | |
| KGKKVDGSVNAYAIN | 116 | Q8WVK2 | |
| EKEGYLQKAKIADGG | 81 | Q53QZ3 | |
| EQSGKEKYKLLVEGD | 1216 | O14802 | |
| KYAAKEGDPDQLSKD | 16 | P29377 | |
| NGAYVKQKLDSKELG | 201 | Q9NTN3 | |
| YCDGKKGFKLAQDQK | 266 | P07225 | |
| IRKKEEDQASQGYKG | 1186 | Q9NRY4 | |
| YKGEDGKAVACNIKV | 241 | Q02040 | |
| EGATYEGIQKKETAK | 196 | O75891 | |
| EKQVYDIAAKFGGLA | 481 | O00116 | |
| QDQGDYGTVKEALLK | 156 | Q53RT3 | |
| EDYLDIKNFGAKVVG | 136 | P51800 | |
| EDYLDIKNFGAKVVG | 136 | P51801 | |
| QGGYKEKFVKTVEDK | 36 | Q13114 | |
| KNGDLDEVKDYVAKG | 11 | P58546 | |
| VENKGYSYKKDGIGL | 81 | Q6IEE8 | |
| DSLVGKQVEYAKEDG | 211 | Q9Y657 | |
| KYNGAVNEIKDLSDK | 306 | Q14BN4 | |
| ELGDGAFGKVYKAKN | 41 | O94804 | |
| AYEVKNGEKFEKLGK | 161 | Q6ZNG0 | |
| KLEGYSEKAQKGDLG | 866 | Q9H5I5 | |
| QDKAGKEKGVLDLSY | 181 | Q5JSZ5 | |
| NYGADEEAAGALLKK | 926 | P02549 | |
| DLQEKLGKQKYFLVG | 461 | P22314 | |
| GKKITDYGGDKEIQN | 176 | O75643 | |
| QEAAKKNYANKAPGE | 1001 | Q502W6 | |
| AVKAGHGYDSKKQQE | 111 | O96006 | |
| CYQKGGAFEKEKLAL | 1721 | O15050 | |
| NKQADAYVEKGILDK | 441 | Q8WXD2 | |
| KGVFVAGYESLKKNE | 36 | Q6P4I2 | |
| EGSKATYEQGVEKDK | 66 | A0A075B6N2 | |
| KARKNYENQGEGKDG | 2296 | Q15911 | |
| YQGADAVGLEEKIKQ | 91 | O43396 | |
| AQAQKALSDVAYKKG | 231 | P20929 |